INTRODUCTION
Curcumin (lE, 6E)-l,7-bis (4-hydroxy-3-methoxyphenyl)-l,6-heptadiene-3,5-dione, also known as diferuloilmetan is a polyphenol present in turmeric rhizomes (Curcuma longa L.), with the content of 5-10% of dry mass. In the Eastern medicine it has been used for centuries for medical purposes. Only recent research begun to investigate its medicinal properties (Sreejayan and Rao, 1997). Many studies have succeeded in the following process of curcumin biotransformation in the body and suggested therapeutic effectiveness against many diseases, including diabetes, asthma, allergies, arthritis, atherosclerosis, neurodegenerative diseases and other chronic diseases such as cancer ( Kainic acid (KA) is a specific agonist of ionotropic glutamate receptors (iGluRs) and a strong neurotoxin (Vincent and Mulle, 2009). KA acts on kainate receptors (KARs) in the central nervous system (CNS) and imitates the excitotoxic action of glutamate in models of neurodegenerative disorders. The KA binding to KARs receptors causes a number of cellular events, including the influx of Ca 2+ into cells, the production of reactive oxygen species (ROS) and reactive nitrogen species (RNS), which leads to the mitochondrial dysfunction, apoptosis of neurons and necrosis (Wang et al., 2005) . Excitotoxicity is considered to be an important mechanism involved in various neurodegenerative diseases in the CNS, such as, for example, Alzheimer's disease (AD), Parkinson's (PD), amyotrophic lateral sclerosis (ALS) and epilepsy (Frantseva et . However, the mechanism via which excitotoxicity is involved in the induction of the disease remains unclear (Zheng et al., 2011) . Accordingly, many researchers are interested in the question of whether it is possible to reduce excitotoxicity and its effects, not only in the CNS, but also in other animal organs. Reduced glutathione (GSH) is the basic non-protein thiol in a cell displaying multiple properties (Dringer et al., 2000; Meister, 1981) . It is considered that it modulates the level of ROS and thus, participates in the cellular response to oxidative stress (Gorrini et al., 2013; Presnell, 2013) . Therefore, the content of GSH in the cell, besides the physiological values, may be a useful indicator of the level of oxidative stress (Pastore et al., 2003) . Hence the question of whether curcumin, which is ascribed antioxidant properties, will affect the changes in the amount of GSH, and, at the same time, in the size of the oxidative stress induced by KA. In the present experiment, we evaluate the amount of GSH in the brain, liver, kidney, pancreas and spleen of mice after the injection of KA alone, as well as after the administration of various doses of curcumin and additional KA after 30 minutes.
MATERIAL AND METHODS
In the experiment consisting of one control group and four experimental groups the total of 40 four-month male white mouse of Swiss strain with an average body weight of 27 g was used. All animals were obtained from the experimental research laboratory of the Department of Animal Physiology and Toxicology, Institute of Biology, Pedagogical University of Cracow. All mice of the control group and the experimental groups included 8 individuals each; animals were kept in suitable cages with full access to the standard food and water throughout the experiment. The lighting was regulated in LD 12:12 cycle (light phase starting at 8 00 till 20 00 ). The breeding room was soundproof, the average temperature was 20°C ± 2°C and the relative humidity equaled 55% ± 5%. Animals of the control group received at 8 00 (at the start of the light phase of LD 12:12) a 0.9 % solution of NaCl (Polfa) in the amount of 0.3 ml as an intraperitoneal injection. In the first group of experimental mice kainic acid (KA) (Sigma, St. Louis, MO) was also intraperitoneally administered at the same time of day, i.e. at 8 00 at a dose of 12 mg/kg body weight (b.w.) dissolved in normal saline (pH adjusted to 7.4 with sodium hydroxide). In turn, the second group of experimental animals received at 8 00 , curcumin (Sigma, St Louis, MO) dissolved in diamethyl sulfoxide (Sigma, St. Louis, MO) at a dose of 50 mg/kg b.w. as an intraperitoneal injection and after 30 mins -KA, also as an intraperitoneal injection at a dose of 12 mg/kg b.w. Mice of the third experimental group received at 8 00 , an intraperitoneal injection of curcumin at 100 mg/kg b.w. and after 30 mins KA was added in the amount of 12 mg/kg b.w. Animals of the fourth experimental group received at 8 00 intraperitoneally curcumin at a dose of 200 mg/kg b.w. and, after 30 mins, KA -at a dose of 12 mg/kg b.w. Mice of the control group were decapitated 4 hrs after the administration of physiological In the present study the effect of various doses administration of curcumin prior to the injection of kainic acid (KA) on the changes in the content of reduced glutathione (GSH) in selected organs of the male white mice were investigated. Animals were conducted in five groups: one control group, four experimental groups. The first experimental group received a single intraperitoneal injection of KA (12 mg/kg b. w.). The second, third and the fourth experimental group were administered intraperitoneally curcumin at doses of 50, 100 and 200 mg/kg b. w. 30 minutes before the injection of KA. In the brain, liver, kidneys, pancreas and spleen of the mice GSH was determined. Administration of KA resulted in a significant change in the amount of GSH in all the examined organs of mice. Injections of curcumin and then KA, caused an increase in GSH compared to a group of animals which received only KA. This increase was not significant only in the group which received curcumin in the lowest dose. Results suggest that curcumin has antioxidant properties because advantageously affected changes in the amount of GSH, and thus the size of the oxidative stress induced by KA. saline, and all the experimental groups -four hours after the injection of kainic acid. Initially, the animals were put into a state of deep anesthesia by intramuscular administration of vetbutal (Biowet, Poland) in the amount of 35 mg/kg b.w. diluted solution of NaCl 0.9% (Polfa). Weighed organs were homogenized in a homogenizer with a Teflon plunger in 6 ml of, cooled up to 4°C, 0.1 M phosphate buffer, pH 7.4, containing 10 mM EDTA. The homogenates were centrifuged in a centrifuge MPW-365 at 4°C for 15 minutes at 15 000 g. Thus obtained supernatants of homogenates of brain, liver, kidney, pancreas and spleen were then deproteinized by adding 500 µl of supernatant into 500 µl TCA and 500 µl EDTA. This mixture was put in the fridge at 4°C for 10 minutes, then centrifuged for 5 min at 5 000 g at 4°C. In the obtained post-centrifugation deproteinized supernatants of brain, liver, kidney, pancreas and spleen GSH concentration was determined using the Ellman's method (Ellman, 1959) . From the results of GSH content in the brain, liver, kidney, pancreas and spleen in the control and experimental groups, arithmetic means and standard deviations were calculated. Percentage changes in the amount of GSH in the experimental groups as compared to the control group were calculated. The results were verified with the use of the statistical test t "Student -Gosset". All statistical calculations of the data obtained during experiments were done with the computer program STATISTICA 9 (StatSoft, Cracow, Poland).
RESULTS AND DISCUSSION

Results
The obtained results of the experiment on GSH determination in the brain, liver, kidney, pancreas and spleen after 4 hours of kainic acid (KA) intraperitoneal administration to the four-week-old male mice, in the amount of 12 mg/kg, of different doses of curcumin (50, 100, and 200 mg/kg. b.w.), and, after 30 minutes, of additional KA are shown in Figure 1 -5. In the mouse brain, in relation to the control values 4 hours after the KA injection, a statistically significant decrease in the GSH content was found (p <0.001; 54.92 %) (Fig. 1) . After the intraperitoneal injection of curcumin at a dose of 50 mg/kg b.w. and KA after 30 mins a slight increase in the content of GSH (6.38%) relative to the group after KA injection but not statistically significant (Fig. 1) was observed. In the animals that received intraperitoneal curcumin at the dose of 100 and 200 mg/kg b.w. and KA after 30 mins statistically significant (p <0.001) increase in the concentration of GSH in the brain, 30.39% and 63.87%, respectively were found (Fig. 1) .
Figure 1
The level of reduced glutathione (GSH) in the brain of control and experimental male mice 4 hours after the intraperitoneal administration of kainic acid (KA) at a dose of 12 mg/kg b.w., (I experimental group), curcumin at a dose of 50 mg/kg b.w., and after 30 min. KA (experimental group II), curcumin at a dose of 100 mg/kg b.w., and KA (III experimental group), curcumin at a dose of 200 mg/kg b.w., and KA (IV experimental group). * -Indicates statistically significant at p < 0.001
In the liver, as compared to the control values, 4 hours after the injection of KA, statistically significant (p <0.001) decrease in GSH concentration was observed (Fig. 2) . This decrease equalled 40.93%. In the group of animals that received curcumin at a dose of 50 mg/kg b.w. followed by additional KA after 30 mins, an increase in GSH level reached 6.14% which was statistically insignificant (Fig.  2) . In turn, the mice after the injection of curcumin in the amount of 100 and 200 mg/kg b.w., followed by KA administration after 30 mins, showed a significant increase in the concentration of this tripeptide in the liver; 19.03% and 48.24%, respectively. In kidneys of animals which received the KA, after 4 hours, the concentration of the tested tripeptide was statistically significant (p <0.001), reduced as compared to the control by 54.62% (Fig. 3) . After the intraperitoneal injection of curcumin at 50 mg/kg, and post additional KA implementation after 30 mins, slightly increased GSH concentration occurred as compared to that obtained from animals receiving only KA. This increase was 8.83% and was statistically insignificant. In mice treated with curcumin intraperitoneally at 100 and 200 mg/kg, followed by additional KA administration after 30 mins a statistically significant (p <0.001) increase in GSH levels, respectively 31.73% and 69.01% (Fig. 3 ) was detected. In male mice, 4 hours after the KA injection, statistically significant (p <0.001) decrease of GSH level was found in the pancreas. This reduction amounted to 31.35% (Fig. 4) . The animals treated with curcumin (50 mg/kg b.m.) followed by additional KA administration after 30 mins, showed an increase in the GSH levels of 6.14% as compared to animals that received KA only. This increase was statistically insignificant (Fig. 4) . Conversely, a statistically significant (p<0.001) increase in the concentration of GSH in the pancreas by 33.09% and 58.88%, respectively was recorded in mice that received curcumin at higher doses and KA after 30 mins (Fig. 4) . In the spleen, compared to the values in the control animals, 4 hours after KA injection, a statistically significant (p <0.001) decrease in GSH concentration was found (Fig. 5) . This decrease was 43.43%. After the intraperitoneal injection of curcumin at 50 mg/kg b.w. and KA after 30 mins, statistically insignificant slight increase of GSH concentration (7.63%) was observed as compared to the animals treated with KA alone. In mice, after the injection of curcumin in the amount of 100 and 200 mg/kg b.w., followed by additional KA administration after 30 mins, significant increase (p <0.001) of this tripeptide level, 19.03% and 48.24% respectively was detected (Fig. 5) .
Figure 5 GSH level in the spleen as in the experiment in Fig.1 . * indicates statistically significant at p<0.001 and ** indicates p<0.01
DISCUSSION
The obtained results show that the administration of the KA caused statistically significant reduction in the amount of GSH in all organs of the examined mice. After the administration of curcumin, followed by additional KA administration after 30 mins, there was a smaller decrease in the amount of GSH in relation to the group of animals which received KA. The decrease in the amount of GSH was respectively smaller when before the KA application higher doses of curcumin were used. After KA administration, it binds to KARs receptors that are present on neurons and microglia. This leads to membrane depolarization, rapid influx of Ca . Undoubtedly, GSH is the most important non-enzymatic antioxidant in the body. This peptide is present in every cell of the body, particularly rich in its resources are kidneys, liver, brain and spleen. GSH directly reacts with radicals in non-enzymatic reactions and is an electron donor in the reduction of superoxide by glutathione peroxidase (Wefers and Sies, 1983). The product of oxidation is glutathione disulfide (GSSG) which is re-reduced by glutathione reductase to GSH (Dringen et al., 2000) . Several studies have shown that the amount of GSH significantly decreased in ischemia (Cooper et al., 1980) , after the supply of ethanol (Calabrese et al., 1998) or compounds with very strong oxidizing properties. Thus, it suggested that the amount of GSH may be one of the markers of oxidative stress and damage to organs (Bukowska, 2004; Bukowska and Kowalska, 2004) . The reduction of GSH post KA administration, found in the current experiment, confirms the data cited by many authors that GSH plays a key role in the adaptation of the cells to cell stress induced by ROS and RNS. The decrease in GSH concentration after the administration of KA can induce not only a reduction in GSH synthesis, but also increase its consumption in the removal of ROS and RNS (Swamy et al., 2009) . The doses of curcumin used in the present experiment inhibited the decrease in the amount of GSH caused by the administration of KA. As already mentioned, curcumin is one of the polyphenolic compounds with antioxidant properties (Giovannini et al., 2006) . Curcumin in micro and millimolar concentration is an effective scavenger of free radicals, such as superoxide anion, hydrogen peroxide and nitric oxide. This compound limits lipid peroxidation and reduced levels of oxidized proteins. Curcumin is capable of maintaining cell status of antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px), and increases the concentration of GSH. Besides antioxidative properties, it also possess anti-inflammatory ones (Rahman, 2006) . It is suggested that curcumin increases the level of cellular GSH and induces the de novo synthesis of GSH, by stimulating the activity and gene expression ligase γ-glutamyl-cysteine (GCL). GCL is an important step of adjusting the speed of the process (Zheng et al., 2007) . Moreover, it has been shown to expression of the gene besides ligase γ-glutamyl-cysteine and increased GSH synthesis that curcumin, in appropriate dose, is cytoprotective because of its strong antioxidant activity and the ability to engage with GSH (Donatus et al., 1990 ).
CONCLUSION
Results of this study describe that curcumin is a potent antioxidant and may protect the organs of the tested mice against oxidative stress induced by the administration of KA. It can be concluded that all doses of curcumin increase the percentage of GSH level in selected tissues to protect against the harmful effects of KA. Supplementing with turmeric may therefore be important research for more research into comprehensive action of the substance and its use in treating diseases.
